Anticoagulation

Vitamin K antagonists (ie. warfarin) allows complete recanalization in about 40-75% of acute, partial portal vein thromboses (and is less effective for complete thromboses).  Extension of clot despite anticoagulation occurs in about 10%.  Bleeding complications are rare (2/75 cases, no mortalities, according to one meta-analysis).